Page last updated: 2024-08-23

mifepristone and Small Cell Lung Carcinoma

mifepristone has been researched along with Small Cell Lung Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ray, DW; Singh, N; Sommer, P; Taylor, KM; Vosloo, D; Wheeler, R1
Mjoli, PB; Poolman, T; Ray, DW; Singh, N; Sommer, P; Taylor, K1

Other Studies

2 other study(ies) available for mifepristone and Small Cell Lung Carcinoma

ArticleYear
The tobacco carcinogen NNK drives accumulation of DNMT1 at the GR promoter thereby reducing GR expression in untransformed lung fibroblasts.
    Scientific reports, 2018, 03-20, Volume: 8, Issue:1

    Topics: Carcinogenesis; Carcinogens; Cell Line; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Mifepristone; Nitrosamines; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Small Cell Lung Carcinoma; Tobacco Smoking

2018
The N-terminal transactivation domain of the glucocorticoid receptor mediates apoptosis of human small cell lung cancer cells.
    Genes, chromosomes & cancer, 2014, Volume: 53, Issue:12

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Humans; Lung Neoplasms; Mifepristone; Promoter Regions, Genetic; Protein Structure, Tertiary; Receptors, Glucocorticoid; Small Cell Lung Carcinoma; Transcriptional Activation

2014
chemdatabank.com